Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.06 HKD
−1.44 B HKD
1.31 B HKD
245.78 M
About AIM VACCINE CO LTD
Sector
Industry
CEO
Yan Zhou
Website
Headquarters
Beijing
Founded
2011
ISIN
CNE100005KF2
FIGI
BBG019STYSW1
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. Its products include Recombinant hepatitis B vaccine, Freeze-dried Human Rabies vaccine, Inactivated Hepatitis A vaccine, Live Attenuated Parotitis vaccine, Inactivated HFRS vaccine, and ACYW135 Meningococcus Polysaccharide vaccine. The company was founded on November 9, 2011 and is headquartered in Beijing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6660 is 6.13 HKD — it has decreased by −1.76% in the past 24 hours. Watch AIM VACCINE CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange AIM VACCINE CO LTD stocks are traded under the ticker 6660.
6660 stock has fallen by −4.81% compared to the previous week, the month change is a −13.42% fall, over the last year AIM VACCINE CO LTD has showed a −8.64% decrease.
6660 reached its all-time high on Mar 13, 2023 with the price of 100.00 HKD, and its all-time low was 3.95 HKD and was reached on Sep 10, 2024. View more price dynamics on 6660 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6660 stock is 3.28% volatile and has beta coefficient of 2.55. Track AIM VACCINE CO LTD stock price on the chart and check out the list of the most volatile stocks — is AIM VACCINE CO LTD there?
Yes, you can track AIM VACCINE CO LTD financials in yearly and quarterly reports right on TradingView.
AIM VACCINE CO LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
6660 net income for the last half-year is −150.90 M HKD, while the previous report showed −1.14 B HKD of net income which accounts for 86.71% change. Track more AIM VACCINE CO LTD financial stats to get the full picture.
No, 6660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 1.62 K employees. See our rating of the largest employees — is AIM VACCINE CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AIM VACCINE CO LTD EBITDA is −155.38 M HKD, and current EBITDA margin is −26.37%. See more stats in AIM VACCINE CO LTD financial statements.
Like other stocks, 6660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM VACCINE CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIM VACCINE CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIM VACCINE CO LTD stock shows the sell signal. See more of AIM VACCINE CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.